Skip to content

Clinical trials

Phase 3 Astrocytoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Astrocytoma Phase: Phase 3 Country / region: Canada Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20061
20071
20081
20093
20161
20171
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Active, not recruiting2
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celtic Pharma Development Services3
European Organisation for Research and Treatment of Cancer - EORTC3
Children's Oncology Group2
Novartis Pharmaceuticals2
Alliance for Clinical Trials in Oncology1
Children's Hospital Los Angeles1
Colorado Health Foundation1
Isarna Therapeutics GmbH1
Orbus Therapeutics, Inc.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Astrocytoma16
Brain Neoplasms9
Central Nervous System Neoplasms7
Glioma5
Oligodendroglioma4
Brain Edema3
Edema3
Glioblastoma3
Neoplasms2
Tuberous Sclerosis2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.